Cargando…
Trend of circulating CD34(+) cells in patients with myelofibrosis: Association with spleen response during ruxolitinib treatment
We evaluated CD34(+) cells in a single‐centre series of 49 consecutive patients with myelofibrosis (MF) at baseline and during ruxolitinib therapy and examined any association with spleen response. The median (range) absolute number of circulating CD34(+) cells was 0.0835 (0.001–1.528) × 10(9)/L at...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10092026/ https://www.ncbi.nlm.nih.gov/pubmed/36266779 http://dx.doi.org/10.1111/bjh.18526 |